Continuous ambulatory peritoneal dialysis and vitamin D

J. Rapoport; S. Shany; C. Chaimovitz

doi:10.1159/000184858

Continuous ambulatory peritoneal dialysis and vitamin D

J. Rapoport
, S. Shany
, C. Chaimovitz

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

CAPD patients present special problems with respect to vitamin D metabolism. Because of substantial losses of vitamin D metabolites in the peritoneal dialysate, they require 2-3 times the oral replacement doses used in hemodialysis patients. Administration of 1,25(OH)₂D₃ or 1-alpha-OH-D₃ should be sufficient to maintain normal levels of 1,25(OH)₂D₃, and to stimulate the renal production of 24,25(OH)₂D₃. However, anephric patients require, in addition, a source of 25OH-D₃, in order to enhance extrarenal production of 24,25(OH)₂D₃.

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Nephron
Volume	48
Issue number	1
DOIs	https://doi.org/10.1159/000184858
State	Published - 1 Jan 1988

ASJC Scopus subject areas

Physiology
Nephrology
Physiology (medical)
Urology

Access to Document

10.1159/000184858

Cite this

@article{b7674a756d934810aa54942eea2a08e6,

title = "Continuous ambulatory peritoneal dialysis and vitamin D",

abstract = "CAPD patients present special problems with respect to vitamin D metabolism. Because of substantial losses of vitamin D metabolites in the peritoneal dialysate, they require 2-3 times the oral replacement doses used in hemodialysis patients. Administration of 1,25(OH)2D3 or 1-alpha-OH-D3 should be sufficient to maintain normal levels of 1,25(OH)2D3, and to stimulate the renal production of 24,25(OH)2D3. However, anephric patients require, in addition, a source of 25OH-D3, in order to enhance extrarenal production of 24,25(OH)2D3.",

author = "J. Rapoport and S. Shany and C. Chaimovitz",

year = "1988",

month = jan,

day = "1",

doi = "10.1159/000184858",

language = "English",

volume = "48",

pages = "1--3",

journal = "Nephron",

issn = "1660-8151",

publisher = "S. Karger AG",

number = "1",

}

TY - JOUR

T1 - Continuous ambulatory peritoneal dialysis and vitamin D

AU - Rapoport, J.

AU - Shany, S.

AU - Chaimovitz, C.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - CAPD patients present special problems with respect to vitamin D metabolism. Because of substantial losses of vitamin D metabolites in the peritoneal dialysate, they require 2-3 times the oral replacement doses used in hemodialysis patients. Administration of 1,25(OH)2D3 or 1-alpha-OH-D3 should be sufficient to maintain normal levels of 1,25(OH)2D3, and to stimulate the renal production of 24,25(OH)2D3. However, anephric patients require, in addition, a source of 25OH-D3, in order to enhance extrarenal production of 24,25(OH)2D3.

AB - CAPD patients present special problems with respect to vitamin D metabolism. Because of substantial losses of vitamin D metabolites in the peritoneal dialysate, they require 2-3 times the oral replacement doses used in hemodialysis patients. Administration of 1,25(OH)2D3 or 1-alpha-OH-D3 should be sufficient to maintain normal levels of 1,25(OH)2D3, and to stimulate the renal production of 24,25(OH)2D3. However, anephric patients require, in addition, a source of 25OH-D3, in order to enhance extrarenal production of 24,25(OH)2D3.

UR - https://www.scopus.com/pages/publications/0023856369

U2 - 10.1159/000184858

DO - 10.1159/000184858

M3 - Review article

C2 - 3277074

AN - SCOPUS:0023856369

SN - 1660-8151

VL - 48

SP - 1

EP - 3

JO - Nephron

JF - Nephron

IS - 1

ER -

Continuous ambulatory peritoneal dialysis and vitamin D

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this